Evidence map›Paper›PMID 33995285›Full record

ArticleFrontiers in endocrinology2021

Health Effects and Life Stage Sensitivities in Zebrafish Exposed to an Estrogenic Wastewater Treatment Works Effluent.

Ruth Cooper, Arthur David, Anke Lange, Charles R Tyler

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Ruth CooperCollege of Life & Environmental Sciences, University of Exeter, Biosciences, Exeter, United Kingdom.
Arthur DavidSchool of Life Sciences, University of Sussex, Brighton, United Kingdom.
Anke LangeCollege of Life & Environmental Sciences, University of Exeter, Biosciences, Exeter, United Kingdom.
Charles R TylerCollege of Life & Environmental Sciences, University of Exeter, Biosciences, Exeter, United Kingdom.
University of Exeter · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K501281/1
6 · The paper itself

Abstract

A wide range of health effects in fish have been reported for exposure to wastewater treatment work (WwTW) effluents including feminized responses in males. Most of these exposure studies, however, have assessed acute health effects and chronic exposure effects are less well established. Using an Estrogen Responsive Element-Green Fluorescent Protein (ERE-GFP)-Casper transgenic zebrafish, we investigated chronic health effects and life stage sensitivities for exposure to an estrogenic WwTW effluent and the synthetic estrogen 17α-ethinylestradiol (EE2). Exposure to the WwTW effluent (at full strength;100%) and to 10 ng/L (nominal) EE2 delayed testis maturation in male fish but accelerated ovary development in females. Exposure to 50% and 100% effluent, and to 10 ng/L EE2, also resulted in skewed sex ratios in favor of females. Differing patterns of green fluorescent protein (GFP) expression, in terms of target tissues and developmental life stages occurred in the ERE-GFP- zebrafish chronically exposed to 100% effluent and reflected the estrogenic content of the effluent.

Indexed as

ReproductionAnimalsEstrogensGene Expression Regulation, DevelopmentalGreen Fluorescent ProteinsVitellogeninsWater Pollutants, ChemicalWater PurificationZebrafishEstrogensGreen Fluorescent ProteinsVitellogeninsWater Pollutants, Chemicalchronicdevelopmenteffluentestrogentransgenicvitellogenin (vtg)zebrafish

Identifiers

PMID33995285
PMCPMC8120895
OpenAlexW3157744882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.